NCT01082978

Brief Summary

The PHF trial will assess the acceptability and long term outcomes resulting from the usage of electronic (carried by the patient on a USB memory device) and paper portable health files in a population with high intensity use of medical services. The rationale is that use of the portable health files provides a conduit of direct communication among health care providers of a patient's important health care information and this leads to better care and patient outcomes. Primary hypothesis: Addition of a patient-held portable health file (PHF) to usual care improves patient outcome and quality-of-life compared to usual care alone. Secondary hypothesis: Addition of patient-held portable health file (PHF) to usual care is acceptable and satisfactory to patients and their health care providers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
382

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 9, 2010

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

August 1, 2017

Status Verified

July 1, 2017

Enrollment Period

9 years

First QC Date

March 8, 2010

Last Update Submit

July 31, 2017

Conditions

Keywords

Quality of LifeHealth Care Quality and SafetyRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Combined endpoint of deaths, hospitalisations (excepting day only hospitalisations), and serious out-of-hospital events

    The primary outcome is the total number of important clinical events (all hospitalisations except same-day hospitalisations, all serious out-of-hospital events and deaths). See above: The assigned treatment (i.e., the e-PHF or p-PHF) will be used for 4 years total. Patients will also be followed for an additional 3 years beyond the conclusion of the randomised trial to see if there are any longer-term lag effects.

    48 months + 36 month extension

Secondary Outcomes (9)

  • Quality of Life

    every 12 months for 48 months

  • health service utilisation and health care costs

    every 12 months for 48 months

  • medication errors, duplicative investigations

    every 12 months for 48 months

  • clinical workflow

    every 6 months for 2 years then every 12 months until 48 months

  • subject and health care provider acceptability and satisfaction with portable health files (PHF)

    every 3 months for 12 months then every 6 months 24 months then every 12 months until 48 months

  • +4 more secondary outcomes

Study Arms (3)

Electronic (USB) Portable Health File

EXPERIMENTAL

Patients randomized to this arm of the trial will be given a USB memory device that contains the Portable Health File (PHF) software. The portable health files contained core medical data which functions as a subset of a comprehensive medical record. The portable health file is updated by the health care provider at each visit and could also be updated by patient between visits if necessary.

Device: Electronic (USB) Portable Health File

Paper Portable Health File

EXPERIMENTAL

Patients randomized to this arm of the trial will be given the paper Portable Health File. The paper Portable Health File contains core medical and other important data which functions as a subset of a more comprehensive medical record. This paper-based portable health file is updated by health care providers at each visit. The PHF can also be updated by patient between visits.

Device: Paper Portable Health File

Usual standard of care

NO INTERVENTION

Patients randomized to this arm of the trial will not be given a Portable Health File. This arm is the concurrent control comparator arm.

Interventions

Patients randomized to this arm of the trial will be given a USB memory device that contains the Portable Health File (PHF) software. The portable health files contained core medical data which functions as a subset of a comprehensive medical record. The portable health file is updated by the health care provider at each visit and could also be updated by patient between visits if necessary.

Also known as: Electronic Personal Health Record, Electronic Patient-Health Provider Shared Medical Record, Electronic Patient-Health Provider Shared Journal, Electronic Patient-carried Shared Medical Record, Electronic Patient-carried Continuity of Care Record
Electronic (USB) Portable Health File

Patients randomized to this arm of the trial will be given the paper Portable Health File. The paper Portable Health File contains core medical and other important data which functions as a subset of a more comprehensive medical record. This paper-based portable health file is updated by health care providers at each visit. The PHF can also be updated by patient between visits.

Also known as: Paper Personal Health Record, Paper Patient-Health Provider Shared Medical Record, Paper Patient-Health Provider Shared Journal, Paper Patient-carried Shared Medical Record, Paper Patient-carried Continuity of Care Record
Paper Portable Health File

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must be of age 60 or greater
  • Patients living independently in the community. Hostel care is acceptable, but patients that are not independent requiring full nursing home care are excluded.
  • Subjects must have had six medical practitioner visits in the previous 12 months
  • Subjects must have at least two of the following confirmed chronic diseases that require prescription oral or parenteral drug treatment or surgery and requiring at least annual specialist consultation: cardiovascular, respiratory, endocrine, renal, neurologic, gastrointestinal, hepatic, genitourinary, haematologic. infective, rheumatic, inflammatory, immunologic or neoplastic disease.
  • \. Subject's GP must have access to a computer during the consultation visit. 7. Subjects must have at least two medical specialists at least one of whom has access to a computer during the consultation visit.
  • \. Subjects must be able to understand the purpose of the trial and undergo full and valid informed consent.

You may not qualify if:

  • Life expectancy of less than 12 months.
  • Inability to carry a paper PHF or e-PHF and having no care-giver willing and able to accomplish same.
  • Mentally unable to undertake valid informed consent.
  • Patients who are not independent in the community, that cannot mobilise to see a specialist or requiring full nursing home care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St George Hospital

Kogarah, New South Wales, 2217, Australia

Location

Related Publications (1)

  • Lassere MN, Baker S, Parle A, Sara A, Johnson KR. Improving quality of care and long-term health outcomes through continuity of care with the use of an electronic or paper patient-held portable health file (COMMUNICATE): study protocol for a randomized controlled trial. Trials. 2015 Jun 4;16:253. doi: 10.1186/s13063-015-0760-8.

Study Officials

  • Marissa ND Lassere, MBBS PhD

    St George Hospital and Univeristy of NSW

    STUDY CHAIR
  • Kent R Johnson, MD

    Newcastle University

    PRINCIPAL INVESTIGATOR
  • George Rubin, MD

    South East Sydney Area Health Service

    PRINCIPAL INVESTIGATOR
  • Anthony Sara, MBBS MBA

    South East Sydney Area Health Service

    PRINCIPAL INVESTIGATOR
  • Andrew Parle, BSc (Hons) PhD

    Consultant

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Primary outcomes, death and overnight hospitalisations, are obtained through record linkage and are masked outcomes. Outcome assessor, however, is not masked to patient-reported outcomes. Chief Investigator and statistical analyses are masked to randomisation/intervention group.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Staff Specialist

Study Record Dates

First Submitted

March 8, 2010

First Posted

March 9, 2010

Study Start

March 1, 2010

Primary Completion

March 1, 2019

Study Completion

March 1, 2020

Last Updated

August 1, 2017

Record last verified: 2017-07

Locations